華興源創(688001.SH):擬發行不超8億元可轉債 用於精密檢測、組裝自動化設備生產基地(一期)等項目
格隆匯5月18日丨華興源創(688001.SH)發佈向不特定對象發行可轉換公司債券預案,擬發行總額不超過人民幣8億元的可轉換公司債券,為期6年。
扣除發行費用後,擬將1.14億元投入精密檢測、組裝自動化設備生產基地(一期),將1.31億元投入精密檢測、組裝自動化設備生產基地(二期),將1.5億元投入下一代平板顯示檢測設備研發及產業化項目,將1.8億元投入半導體SIP芯片測試設備產業化項目,將2.25億元用於補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.